2016 News Releases – Quarter 3
2016 News Releases – Quarter 2
2016 News Releases – Quarter 1
- 03/15/2016
U.S. Stem Cell, Inc. Reports Positive Results for 10K 2015 - 02/17/2016
CSO Kristin Comella Publishes Paper on the Integration of Stem Cells to Chondrocyte Derived Cartilage - 02/9/2016
Dr. William P. Murphy delivers Keynote Address at the Academy of Regenerative Practices
2015 News Releases – Quarter 4
- 12/04/2015
U.S. Stem Cell Now Trading USRM; Completes Financing Transaction - 12/03/2015
U.S. Stem Cell Announces Positive Results for Traumatic Brain Injury (TBI) Patients - 11/06/2015
U.S. Stem Cell, Inc. Reports Positive Results for 3Q - 11/04/2015
Bioheart Receives Approal for Reverse Split and Name Change
2015 News Releases – Quarter 3
- 09/17/2015
US STEMCELL (Bioheart) Announces Insiders Intend to Purchase Company Common Stock in the Open Market - 09/14/2015
Kristin Comella, US STEMCELL (Bioheart) CSO, Speaks at World Stem Cell and Regenerative Medicine Congress - 08/27/2015
Bioheart to Change Name to U.S. Stemcell, Inc.; SEC Approval for Reverse Stock Split Filed - 08/18/2015
Bioheart Reports Continuing Financial Achievements in First Half and Second Quarter 2015 Results
2015 News Releases – Quarter 2
- 6/08/2015
Bioheart CEO Tomas Voted Top Entrepreneur - 6/03/2015
Bioheart enters into an agreement with Pavillion Scientific - 5/23/2015
Bioheart Chairman Affirms Corporate Strategy Through Stock Purchase – REVISED - 5/22/2015
Bioheart Chairman Affirms Corporate Strategy Through Stock Purchase - 5/6/2015
Bioheart Highlights Positive First Quarter Results - 4/20/2015
Bioheart Posts Contact Information for its Upcoming Conference Call - 4/16/2015
US Stem Cell Clinic Increases Staff to Support Patient Demand and Marketing - 4/15/2015
Bioheart to Preview Positive 1st Quarter Results in Upcoming Conference Call
2015 News Releases – Quarter 1
- 3/19/2015
Bioheart and Ascyrus Medical Execute Investment Agreement - 3/17/2015
Bioheart Touts 2014 Accomplishments; Seeks More in 2015 - 2/11/2015
Bioheart Strengthens Management Team with Appointment of Martin E. Schmieg as President of Vetbiologics, Inc. - 1/29/2015
Bioheart Updates and Diversifies Its Clinical Development Pipeline - 1/28/2015
Bioheart Confirms Date and Access for Shareholder Conference Call - 1/14/2015
Bioheart Announces Date for Shareholder Conference Call - 1/13/2015
Bioheart Board of Directors Authorizes a Repurchase of the Company’s Outstanding Common Stock